Blog

New guidelines enhance systemic therapy for hepatocellular carcinoma

Updated clinical practice guidelines provide evidence-based recommendations for systemic therapy in hepatocellular carcinoma management. Researchers highlight the introduction of new targeted therapies and immune-checkpoint inhibitors to address critical issues, including recurrence after curative treatment and disease progression among patients ineligible for other therapies. Enhanced understanding of immune-related adverse events contributes to improved patient management. This guideline emphasizes targeted approaches, ensuring optimal treatment pathways for patients suffering from this high-mortality cancer.

Editorial by Lau G, Obi S (…) Omata M et 55 al. in Hepatol Int

© 2024. Asian Pacific Association for the Study of the Liver.

read the whole article in Hepatol Int

open it in PubMed

Bariatric surgery significantly reduces long-term mortality in cirrhosis patients

In a retrospective cohort study of 91,708 patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis, bariatric surgery markedly decreased mortality risks. Those who underwent the procedure showed a 5-year overall mortality of 24.9%, compared to 37.1% in non-surgical counterparts. Significant reductions were also observed in liver-related (3.3% vs. 14%) and non-liver-related mortality (22.3% vs. 26.9%). Specifically, laparoscopic surgeries contributed to lower mortality rates, while open surgeries were linked to increased risks.

Journal Article by Rouillard NA, Barnett SD (…) Nguyen MH et 4 al. in Clin Mol Hepatol

read the whole article in Clin Mol Hepatol

open it in PubMed

Early surgery outperforms endoscopy in chronic pancreatitis patients

A long-term follow-up study reveals that early surgery significantly reduces pain and enhances patient satisfaction compared to an endoscopy-first approach in chronic pancreatitis patients. After an average of 98 months, the early surgery group reported lower pain scores (33 vs. 51) and a higher rate of complete pain relief (45% vs. 20%). Additionally, satisfaction with treatment also favored the early surgery group (71% vs. 33%). Patients transitioning from endoscopy to surgery experienced poorer outcomes.

Journal Article by van Veldhuisen CL, Kempeneers MA (…) Issa Y et 27 al. in JAMA Surg

read the whole article in JAMA Surg

open it in PubMed

Screen-detected colon cancer leads to better outcomes.

Long-term outcomes for screen-detected right-sided colon cancer patients significantly outperformed those of symptomatic cases. In a cohort of 909 patients, screen-detected individuals exhibited higher rates of early-stage lesions, achieving 98% R0 resection compared to lower rates in elective (93.3%) and emergency cases (79.4%). After five years, survival rates were 85.4% for screen-detected patients compared to 75.4% and 53.1% for elective and emergency cases, respectively. Recurrence rates also favored the screen-detected group at 8%.

Journal Article by Lucocq J, Trinder T (…) Muthukumarasamy G et 4 al. in World J Surg

© 2024 The Author(s). World Journal of Surgery published by John Wiley & Sons Ltd on behalf of International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).

read the whole article in World J Surg

open it in PubMed

Cytoreductive surgery enhances survival in colorectal cancer patients.

A bicentric analysis revealed that patients with colorectal cancer peritoneal metastases (crpm), particularly when isolated or with limited extraperitoneal metastases (epm), experience significantly improved median overall survival (58 months vs. 39 months) following cytoreductive surgery. The study involved 413 patients, demonstrating similar postoperative outcomes between those with and without epm. Notably, specific prognostic groups identified distinct survival rates, emphasizing effective treatment strategies for selected patients with limited peritoneal involvement.

Journal Article by Sourrouille I, Pastier C (…) Goéré D et 5 al. in Eur J Surg Oncol

Copyright © 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

read the whole article in Eur J Surg Oncol

open it in PubMed

Consensus recommendations established for enhanced recovery in hernia surgery

This research analyzed 295 elements from six specialized centers, pinpointing 24 key themes across every stage of ventral hernia repair. By assessing current enhanced recovery after surgery (ERAS) protocols, the study showcases a unified framework that may help standardize practices and improve patient outcomes. The proposed consensus recommendations were crafted by the ACHQC Quality Improvement Committee to address the significant variation in existing protocols, paving the way for more effective guidelines in hernia surgery recovery.

Journal Article by Remulla D, Bradley JF (…) Beffa LR et 3 al. in Hernia

© 2024. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.

read the whole article in Hernia

open it in PubMed

Two predictive models for HCC recurrence developed successfully

A study identified a 70.9% postoperative recurrence rate for type iii-iv in hepatocellular carcinoma (HCC) patients with macroscopic vascular invasion. Key independent risk factors included young age, large tumor size (≥10 cm), and high Ki67 index. Two nomograms—pre- and postoperative—demonstrated strong prediction capabilities with ROC curve areas of 0.827 and 0.891, respectively. Both models effectively categorized patients into distinct prognosis subgroups, offering valuable insights for treatment strategies in clinical settings.

Journal Article by Huang Y, Su Y (…) Qi L et 6 al. in World J Surg Oncol

© 2024. The Author(s).

read the whole article in World J Surg Oncol

open it in PubMed

ctDNA dynamics significantly predict recurrence in cholangiocarcinoma patients

Monitoring circulating tumor DNA (ctDNA) provides critical prognostic insights for patients with resected extrahepatic cholangiocarcinoma (eCCA). Findings demonstrate that ctDNA positivity before and during adjuvant chemotherapy is associated with significantly inferior disease-free survival (DFS). Notably, patients who remained ctDNA-negative experienced a markedly longer DFS. These results emphasize ctDNA’s potential in guiding clinical decisions concerning treatment strategies and may enhance personalized interventions aimed at reducing recurrence rates in this high-risk patient population.

Journal Article by Yoo C, Jeong H (…) Liu MC et 23 al. in J Hepatol

Copyright © 2024. Published by Elsevier B.V.

read the whole article in J Hepatol

open it in PubMed

Sustained Virological Response Enhances Survival in HCV-Related Liver Cancer

A study of 216 patients with hepatitis C virus-related hepatocellular carcinoma demonstrated that those achieving a sustained virologic response (SVR) through direct-acting antiviral therapy, either pre- or post-surgery, had significantly improved overall and recurrence-free survival rates compared to those without SVR. Specifically, the hazard ratios indicated that SVR was a strong independent predictor of both outcomes. Furthermore, patients achieving SVR with direct-acting antivirals showed better survival rates than those using interferon.

Journal Article by Abe H, Okamura Y (…) Masuda S et 8 al. in Ann Surg Oncol

© 2024. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Radiomics features may enhance survival prediction for PDAC patients

A study involving 131 non-surgical pancreatic ductal adenocarcinoma patients revealed that radiomics features from baseline CT images could significantly predict overall survival. Out of 845 extracted features, 45 were notably different among survival tertiles. The developed radiomics score demonstrated significant differentiation (p = 0.034) and overall survival differences (p = 0.02). The predictive nomogram exhibited good calibration, indicating the potential of integrating radiomics with semantic imaging to enhance prognostication for PDAC patients.

Journal Article by Madani SP, Mirza-Aghazadeh-Attari M (…) Kamel IR et 8 al. in J Gastrointest Surg

Copyright © 2024. Published by Elsevier Inc.

read the whole article in J Gastrointest Surg

open it in PubMed